AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news

Biotech

20 stories about Biotech
שינוי אקלים

Saving the planet, one innovation at a time

20.09.21|Yafit Ovadia
The Smart Agro R&D Partnership invests in Israeli agritech, foodtech, and other sustainable technologies to save food sources, namely plants and bees. “We’re solving big issues with technology,” said CEO Dganit Vered
Betalin Therapeutics Nikolai Kunicher

Betalin Therapeutics receives EU equity investment for its alternative insulin therapy

21.07.21|James Spiro
The Biomed startup seeks to eliminate the need for insulin injections and glucose testing
מימין דוקטור יהושוע גלייטמן אבנר לושי ופרופסור שלמה נו

Shuki Gleitman's GIBF raising $300 million in China for second biotech fund

31.05.21|Golan Hazani
The Guangzhou Sino-Israel Biotech Investment Fund (GIBF) focuses on life science investments and cooperates with leading Guangzhou organizations to bring Israeli biotech firms to the massive Chinese metropolitan
איתן סטיבה בכנס הכרזת הניסויים

Which Israeli technologies will soon be going to space?

05.05.21|Yafit Ovadia
Space Hummus, onboard drones, flexible solar panels, and cameras to photograph “lightning elves” are just some of the Israeli technologies that will accompany the next Israeli astronaut to space in 2022
מימין: ד״ר דוד סידרנסקי עידו צאירי ד״ר יובל קבילי קרן השקעות Israel Biotech Fund

Israel Biotech Fund ready to expand portfolio after closing $112 million second fund

05.04.21|Meir Orbach
The fund will focus on the investment and formation of Israeli biotech and pharma companies developing drugs at different stages of development and for various indications
גילי רגב מנכ"לית סנוטייז

Israel and New Zealand approve anti-Covid-19 nasal spray

23.03.21|Reuters
Both countries granted approval for the sale of Canadian biotech company SaNOtize’s nasal spray, which has proven effective at preventing spread of virus
עפר גונן מנכ"ל כלל ביוטכנולוגיה

CBI plans to issue new SPAC to merge with Israeli life science company

18.03.21|Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
משרדי בורסת נאסד"ק ב ניו יורק

ForeBio is on its way to Nasdaq at a $500 million valuation

01.03.21|Tzally Greenberg
The company aims to raise $100 million in an April IPO, while Pontifax and OrbiMed who previously invested $21 million for a 12.5% stake in ForeBio’s shares are expected to make a $120 million profit
גילי רגב מנכ"לית סנוטייז

"Our nasal spray is like a hand sanitizer for your nose and can block 99.9% of Covid-19 viruses," says CEO

13.01.21|Yafit Ovadia
After new Covid-strains emerge, SaNOtize’s nasal spray is being used in clinical trials in the U.K. and Canada, with plans to be rolled out in the U.S. soon
עסק קטן הקמת עסק סטארטאפ תוכנית עסקים קטנים 2

Startup+ Competition: These startups create innovative products for everyday use

14.12.20|Meir Orbach
Reducing the risk of bodies’ rejecting implants, easy-to-use information about real estate data, and a support network for abused women are just some of the tech solutions featured in Calcalist’s Startup+ competition that can be used every day
Yfat Scialom OutSense

Tech in your toilet: OutSense raises $2.2 million for device that tests poo for health risks

09.11.20|James Spiro
Attaching its IoT device to a toilet bowl, bathroom visitors can help catch cancers and other diseases, company aims to create the world’s largest database of human waste
פאריד אל זארוני Fareed Al Zarooni יו"ר AngelWorld BioTech כנס אמירויות

“This is a great opportunity to secure ties and relationships with our cousins in Israel,” says Emirati executive

01.11.20|CTech
"I have seen a lot of projects built on trust in the past and today they are worth billions," says Farid Al Zarooni chairman of AngelWorld BioTech
ד"ר ערן אדן מנכל מי מד MeMed

MeMed analyzes complex immune responses to answer simple health questions

26.10.20|Yafit Ovadia
Growing biotechnology company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers
מימין תומר קריב ו רן נוסבאום מנהלי קרן פונטיפקס

Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold

12.10.20|Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
default image

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
מימין נועם סולומון ו לואיס וולוך

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20|Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
ד"ר יאיר שינדל מוסף שבועי 13.2.20

Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

21.02.20| Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
איל ליפשיץ פלגרין

Peregrine Ventures Raises Fourth $115 Million Fund

09.12.19|CTech
The Israeli medtech venture firm now has over $200 million under management
סטיבן מנושין סטיבן מנוצ'ין שר האוצר ארה"ב

Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch

29.10.19|Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
Previous ArticlesMore Articles